Dr. Neil Bressler has been a member of the Wilmer Eye Institute's faculty since 1988 and is the inaugural James P. Gills Professor of Ophthalmology. He specializes in retinal diseases, with special interests in diabetic retinopathy and macular degeneration. Dr. Bressler's main research interests have been collaborative efforts in clinical trials of common retinal diseases, including age-related macular degeneration and diabetic retinopathy, having chaired several NIH-sponsored and industry-sponsored multicenter randomized clinical trials and authored almost 300 peer-reviewed publications. He is a past chair of the NIH-sponsored Diabetic Retinopathy Clinical Research Network, and was responsible for guidelines, policies, protocol development as well as implementation, and to facilitate Network operations in a way that maintains academic integrity and optimal clinical trial performance. He also has chaired the National Eye Institutes Data and Safety Monitoring Committee for intramural clinical trials and the FDA Ophthalmic Devices Panel. Dr. Bressler is currently editor-in-chief of JAMA Ophthalmology. Dr. Bressler is rated as an Elite provider by MediFind in the treatment of Diabetic Macular Edema (DME). His top areas of expertise are Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal.

Lloyd Aiello is an Ophthalmologist in Boston, Massachusetts. Dr. Aiello is rated as an Elite provider by MediFind in the treatment of Diabetic Macular Edema (DME). His top areas of expertise are Diabetic Retinopathy, Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Vitrectomy, and Cataract Removal.

Dr. Susan Bressler is the Julia G. Levy, Ph.D. Professor of Ophthalmology at the Wilmer Eye Institute. She is an ophthalmologist and has subspecialty training in medical retinal disorders, vitreoretinal disease, and retinal surgery. Her main research interest has been collaborative efforts in clinical trials - serving as principal investigator of an image reading center that has served as a central unit for many clinical trials and epidemiologic investigations, as Vice Chair of the Diabetic Retinopathy Clinical Research Network and as principal investigator of a participating clinical center in several major clinical trials. Most studies have specific emphasis on the treatment of both non-neovascular and neovascular age-related macular degeneration and all aspects of diabetic retinopathy. Dr. Bressler has a large national and international referral practice. In addition, she has published 223 peer reviewed articles and 55 book chapters. Editorial Board positions have included American Journal of Ophthalmology, Survey of Ophthalmology, Retina, EyeNet Magazine, Health After 50: The Johns Hopkins Medical Letter and the Wilmer Retina Update. Dr. Bressler is rated as an Elite provider by MediFind in the treatment of Diabetic Macular Edema (DME). Her top areas of expertise are Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, and Vitrectomy.

Peter A. Campochiaro, M.D. is the George S. and Dolores Doré Eccles Professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. He is a clinician-scientist who directs a research laboratory and conducts clinical trials. His laboratory research is directed at understanding the pathogenesis of ocular neovascularization and excessive retinal vascular permeability, and the mechanism of cone cell death in inherited retinal degenerations. He helped to determine the importance of vascular endothelial growth factor (VEGF), hypoxia-inducible factor-1, and Tie2 in retinal and choroidal vascular diseases. The clinical trial group under Dr. Campochairo provided the first demonstration of the benefits of suppression of VEGF in diabetic macular edema and retinal vein occlusion. He has developed strategies for sustained suppression of VEGF that are currently being tested in clinical trials. Dr. Campochiaro trained at the University of Notre Dame, Johns Hopkins School of Medicine, and the University of Virginia. He did a vitreoretinal fellowship and research fellowships at Johns Hopkins and joined the faculty of the University of Virginia in 1984. He became professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins in 1991. Dr. Campochiaro is rated as an Elite provider by MediFind in the treatment of Diabetic Macular Edema (DME). His top areas of expertise are Retinal Vein Occlusion, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Trabeculectomy, and Vitrectomy.

Peter Kaiser is an Ophthalmologist in Cleveland, Ohio. Dr. Kaiser has been practicing medicine for over 38 years and is rated as an Elite provider by MediFind in the treatment of Diabetic Macular Edema (DME). His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, Vitrectomy, and Osteotomy.

Jay Chhablani is an Ophthalmologist in Pittsburgh, Pennsylvania. Dr. Chhablani is rated as an Elite provider by MediFind in the treatment of Diabetic Macular Edema (DME). His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Cataract Removal. Dr. Chhablani is currently accepting new patients.

Lee Jampol is an Ophthalmologist in Chicago, Illinois. Dr. Jampol has been practicing medicine for over 57 years and is rated as an Elite provider by MediFind in the treatment of Diabetic Macular Edema (DME). His top areas of expertise are Diabetic Macular Edema (DME), Diabetic Retinopathy, Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE), Age-Related Macular Degeneration (ARMD), and Vitrectomy.

Glenn Jaffe is an Ophthalmologist and a General Surgeon in Durham, North Carolina. Dr. Jaffe is rated as a Distinguished provider by MediFind in the treatment of Diabetic Macular Edema (DME). His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Vitrectomy, and Trabeculectomy. Dr. Jaffe is currently accepting new patients.

Hemal Mehta is an Intensive Care Medicine provider in Flemington, New Jersey. Dr. Mehta is rated as an Elite provider by MediFind in the treatment of Diabetic Macular Edema (DME). His top areas of expertise are Diabetic Macular Edema (DME), Lung Metastases, Pulmonary Fibrosis, and Pneumonia.

Sobha Sivaprasad practices in London, United Kingdom. Sivaprasad is rated as an Elite expert by MediFind in the treatment of Diabetic Macular Edema (DME). Their top areas of expertise are Diabetic Retinopathy, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Trabeculectomy.

Ursula Erfurth-Schmidt practices in Vienna, Austria. Ms. Erfurth-Schmidt is rated as an Elite expert by MediFind in the treatment of Diabetic Macular Edema (DME). Her top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Vitrectomy, and Cataract Removal.

Mark Gillies practices in Sydney, Australia. Mr. Gillies is rated as an Elite expert by MediFind in the treatment of Diabetic Macular Edema (DME). His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Macular Edema (DME), Cataract Removal, and Vitrectomy.

Tomoaki Murakami practices in Fuchu, Japan. Mr. Murakami is rated as an Elite expert by MediFind in the treatment of Diabetic Macular Edema (DME). His top areas of expertise are Diabetic Macular Edema (DME), Diabetic Retinopathy, Retinal Vein Occlusion, Vitrectomy, and Thrombectomy.

Anat Loewenstein practices in Tel Aviv, Israel. Ms. Loewenstein is rated as an Elite expert by MediFind in the treatment of Diabetic Macular Edema (DME). Her top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Macular Edema (DME), Vitrectomy, and Cataract Removal.

Diana Do is an Ophthalmologist in San Jose, California. Dr. Do is rated as an Elite provider by MediFind in the treatment of Diabetic Macular Edema (DME). Her top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Diabetic Macular Edema (DME), Vitrectomy, and Cataract Removal.

Giuseppe Querques practices in Creteil, France. Mr. Querques is rated as an Elite expert by MediFind in the treatment of Diabetic Macular Edema (DME). His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Vitrectomy, and Cataract Removal.

Ramin Tadayoni practices in Paris, France. Mr. Tadayoni is rated as an Elite expert by MediFind in the treatment of Diabetic Macular Edema (DME). His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Vein Occlusion, Vitrectomy, and Cataract Removal.

Focke Ziemssen practices in Tuebingen, Germany. Ziemssen is rated as an Elite expert by MediFind in the treatment of Diabetic Macular Edema (DME). Their top areas of expertise are Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Trabeculectomy.

Jakob Grauslund practices in Odense, Denmark. Mr. Grauslund is rated as an Elite expert by MediFind in the treatment of Diabetic Macular Edema (DME). His top areas of expertise are Diabetic Retinopathy, Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Vitrectomy, and Cataract Removal.

Christos Haritoglou practices in Munich, Germany. Mr. Haritoglou is rated as an Elite expert by MediFind in the treatment of Diabetic Macular Edema (DME). His top areas of expertise are Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal.